NL179205C - Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van voor toepassing daarbij geschikte aminoalkylesters van xantheen-9-carbonzuur. - Google Patents
Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van voor toepassing daarbij geschikte aminoalkylesters van xantheen-9-carbonzuur.Info
- Publication number
- NL179205C NL179205C NLAANVRAGE7211966,A NL7211966A NL179205C NL 179205 C NL179205 C NL 179205C NL 7211966 A NL7211966 A NL 7211966A NL 179205 C NL179205 C NL 179205C
- Authority
- NL
- Netherlands
- Prior art keywords
- preparation
- xanthen
- carbonic acid
- pharmaceutical preparations
- acid suitable
- Prior art date
Links
- 238000000034 method Methods 0.000 title 2
- 238000002360 preparation method Methods 0.000 title 2
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/78—Ring systems having three or more relevant rings
- C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
- C07D311/82—Xanthenes
- C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HURI444A HU163608B (cs) | 1971-09-03 | 1971-09-03 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL7211966A NL7211966A (cs) | 1973-03-06 |
| NL179205B NL179205B (nl) | 1986-03-03 |
| NL179205C true NL179205C (nl) | 1986-08-01 |
Family
ID=11000874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NLAANVRAGE7211966,A NL179205C (nl) | 1971-09-03 | 1972-09-01 | Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van voor toepassing daarbij geschikte aminoalkylesters van xantheen-9-carbonzuur. |
Country Status (18)
| Country | Link |
|---|---|
| AT (1) | AT323741B (cs) |
| AU (1) | AU4622172A (cs) |
| BE (1) | BE788289A (cs) |
| CA (1) | CA1008075A (cs) |
| CH (1) | CH577957A5 (cs) |
| CS (1) | CS168004B2 (cs) |
| DD (1) | DD102142A5 (cs) |
| DE (2) | DE2243143C3 (cs) |
| DK (1) | DK144821C (cs) |
| ES (1) | ES406345A1 (cs) |
| FI (1) | FI56007C (cs) |
| GB (1) | GB1407456A (cs) |
| HU (1) | HU163608B (cs) |
| IL (1) | IL40169A (cs) |
| NL (1) | NL179205C (cs) |
| PL (1) | PL90702B1 (cs) |
| SU (1) | SU631068A3 (cs) |
| YU (1) | YU35762B (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004045220A1 (de) * | 2004-09-17 | 2006-04-06 | Riemser Arzneimittel Ag | Neue Arzneimittel |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1445551A1 (de) * | 1964-12-10 | 1969-05-22 | Boheringer Mannheim Gmbh | Verfahren zur Herstellung neuer,basisch substituierter Xanthen-9-o1-9-carbonsaeureester und deren Salzen |
| US3523950A (en) * | 1967-12-13 | 1970-08-11 | Robins Co Inc A H | Certain 4 - phenyl - 1,2,3,6 - tetrahydropyridyl-n-lower alkylene-ureas and derivatives |
-
0
- BE BE788289D patent/BE788289A/xx not_active IP Right Cessation
-
1971
- 1971-09-03 HU HURI444A patent/HU163608B/hu unknown
-
1972
- 1972-08-21 IL IL40169A patent/IL40169A/en unknown
- 1972-08-24 GB GB3953372A patent/GB1407456A/en not_active Expired
- 1972-08-29 DD DD165299A patent/DD102142A5/xx unknown
- 1972-08-30 CH CH1277072A patent/CH577957A5/xx not_active IP Right Cessation
- 1972-08-31 CS CS725981A patent/CS168004B2/cs unknown
- 1972-08-31 FI FI2404/72A patent/FI56007C/fi active
- 1972-09-01 DK DK434872A patent/DK144821C/da not_active IP Right Cessation
- 1972-09-01 DE DE2243143A patent/DE2243143C3/de not_active Expired
- 1972-09-01 DE DE2265580A patent/DE2265580C2/de not_active Expired
- 1972-09-01 AU AU46221/72A patent/AU4622172A/en not_active Expired
- 1972-09-01 AT AT752372A patent/AT323741B/de not_active IP Right Cessation
- 1972-09-01 CA CA150,771A patent/CA1008075A/en not_active Expired
- 1972-09-01 PL PL1972157546A patent/PL90702B1/pl unknown
- 1972-09-01 NL NLAANVRAGE7211966,A patent/NL179205C/xx not_active IP Right Cessation
- 1972-09-01 YU YU2211/72A patent/YU35762B/xx unknown
- 1972-09-02 ES ES406345A patent/ES406345A1/es not_active Expired
- 1972-09-02 SU SU721827725A patent/SU631068A3/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| CH577957A5 (cs) | 1976-07-30 |
| SU631068A3 (ru) | 1978-10-30 |
| YU221172A (en) | 1980-10-31 |
| BE788289A (fr) | 1973-01-02 |
| CS168004B2 (en) | 1976-05-28 |
| AU4622172A (en) | 1974-03-07 |
| NL179205B (nl) | 1986-03-03 |
| DK144821B (da) | 1982-06-14 |
| YU35762B (en) | 1981-06-30 |
| DD102142A5 (cs) | 1973-12-05 |
| IL40169A (en) | 1976-04-30 |
| DE2243143B2 (de) | 1980-10-09 |
| DE2243143C3 (de) | 1982-01-21 |
| FI56007B (fi) | 1979-07-31 |
| NL7211966A (cs) | 1973-03-06 |
| CA1008075A (en) | 1977-04-05 |
| GB1407456A (en) | 1975-09-24 |
| DE2265580C2 (de) | 1982-11-18 |
| DE2243143A1 (de) | 1973-04-12 |
| HU163608B (cs) | 1973-09-27 |
| IL40169A0 (en) | 1972-10-29 |
| DK144821C (da) | 1982-11-01 |
| ES406345A1 (es) | 1976-01-16 |
| AT323741B (de) | 1975-07-25 |
| FI56007C (fi) | 1979-11-12 |
| PL90702B1 (en) | 1977-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL150680B (nl) | Werkwijze ter bereiding van farmaceutische preparaten. | |
| NL189459C (nl) | Werkwijze voor het bereiden van een 2-aryl-propionzuur en een farmaceutisch preparaat daarvan. | |
| NL170140C (nl) | Werkwijze ter bereiding van farmaceutische preparaten, de door toepassing daarvan verkregen gevormde voortbrengselen, alsmede werkwijze ter bereiding van 1,4-dihydropyridine 3,5-dicarbonzuuresters. | |
| NL174547C (nl) | Werkwijze ter bereiding van benzoylpropionzuurderivaten, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten. | |
| NL7601455A (nl) | Werkwijze ter bereiding van prostaglandine-analo- ga; werkwijze ter bereiding van farmaceutische preparaten, alsmede gevormde voortbrengselen. | |
| NL7501032A (nl) | Werkwijze ter bereiding van anti-tuberkelmid- delen, alsmede farmaceutische preparaten die deze middelen bevatten. | |
| NL170535C (nl) | Werkwijze voor het bereiden van asymmetrische 1.4-dihydropyridine 3.5-dicarbonzuuresters, alsmede voor het bereiden van farmaceutische preparaten en de onder toepassing daarvan verkregen gevormde voortbrengselen. | |
| NL168820C (nl) | Werkwijze voor het bereiden van 2-(6-methoxy-2-naftyl)-propionzuur en werkwijze ter bereiding of vervaardiging van een farmaceutisch preparaat op basis van 2-(6-methoxy-2-naftyl)-propionzuur. | |
| NL179729C (nl) | Werkwijze ter bereiding van farmaceutische preparaten op basis van 1h-indazool-3-carbonzuurderivaten alsmede werkwijze ter bereiding van deze 1h-indazool-3-carbonzuurderivaten. | |
| NL186575C (nl) | Werkwijze ter bereiding van aminoalkaan-1,1-difosfonzuren, alsmede werkwijze ter bereiding van een farmaceutisch of cosmetisch preparaat. | |
| NL168210B (nl) | Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van cyclische carbon- zuurderivaten. | |
| NL173400C (nl) | Werkwijze ter bereiding van farmaceutische preparaten op basis van 2-gesubstitueerde-5-sulfamylbenzoezuren, alsmede werkwijze ter bereiding van 2-gesubstitueerde-5-sulfamylbenzoezuren. | |
| NL7610057A (nl) | Werkwijze voor de bereiding van farmaceutische preparaten. | |
| NL7508706A (nl) | Werkwijze ter bereiding van pyrazofurinederivaten, alsmede werkwijze ter bereiding van farmaceutische preparaten. | |
| NL7605446A (nl) | Werkwijze ter bereiding van een therapeutisch preparaat alsmede werkwijze ter bereiding van een daarvoor geschikt benzofenonderivaat. | |
| NL185841C (nl) | Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van voor toepassing daarbij geschikte 5-mercaptopyridoxinederivaten. | |
| NL172446C (nl) | Werkwijze voor de bereiding van 4-aryl-1-(4.4-diarylbutyl)4-hydroxypiperidinen en werkwijze voor de bereiding van farmaceutische preparaten. | |
| NL7611974A (nl) | Werkwijze ter bereiding van fenylnaftaleenderi- vaten, alsmede werkwijze ter bereiding van far- maceutische preparaten. | |
| NL179205B (nl) | Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van voor toepassing daarbij geschikte aminoalkylesters van xantheen-9-carbonzuur. | |
| NL7609266A (nl) | Werkwijze ter bereiding van hydroxyzuren, werk- wijze ter vervaardiging van farmaceutische preparaten hiermede, alsmede de aldus gevormde voortbrengselen. | |
| NL164037C (nl) | Werkwijze ter bereiding van 1,4-dithiino- -2,3-cpyrrool-derivaten en van farmaceutische preparaten die deze derivaten bevatten. | |
| NL175063C (nl) | Werkwijze ter bereiding van 11,11-alkylideensteroiden, werkwijze ter bereiding van farmaceutische preparaten en gevormde farmaceutische preparaten. | |
| NL7610808A (nl) | Werkwijze ter bereiding van een farmaceutisch preparaat en werkwijze ter bereiding van anti- biotica. | |
| NL175827C (nl) | Werkwijze voor het bereiden van alfa-(5-indanyloxycarbonyl)-benzylpenicilline en van farmaceutische preparaten daaruit. | |
| NL149082B (nl) | Werkwijze ter bereiding van farmaceutische preparaten, gevormde preparaten en werkwijze ter bereiding van daarvoor geschikte thiazolino (3,2-a)-5-pyrimidinonderivaten. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA | A request for search or an international-type search has been filed | ||
| BT | A notification was added to the application dossier and made available to the public | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| A85 | Still pending on 85-01-01 | ||
| V1 | Lapsed because of non-payment of the annual fee |